Peak Processing Limited (ASX: PKP)
Health Care · Pharmaceuticals · AU
AU$0.02
-6.25% today · -25.0% 1Y
Peak Processing Limited (ASX: PKP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $14.19M and employs 0 people.
Over the last twelve months the share price has lost 25.0%, trading between 0.01 and 0.02.
Tweenvest scores Peak Processing Limited across four factors: quality 16/100, value 66/100, growth 78/100. Its strongest factor is growth.
PKP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.19M
- Revenue (TTM)
- $9.73M
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- 1.34
- 52-week high
- AU$0.02
- 52-week low
- AU$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 1.33B
- Employees
- 0
- Next earnings
- —
About Peak Processing Limited
Based in Melbourne, Australia, and founded in 2016, Peak Processing Limited, alongside its subsidiaries, is engaged in the manufacturing, distribution, and sale of recreational cannabis products throughout Canada and the United States. Its extensive product line, available through retail outlets, features items such as beverages, hydrocarbon extracts, various oils, vapes, topicals, powders, infused flowers, and edibles. Furthermore, the company provides a suite of services, including market analysis, product development, production, commercialization strategies, logistical distribution, and product refurbishment. Notably, the firm was previously known as Althea Group Holdings Limited and is slated to officially change its name to Peak Processing Limited in November 2025.
- ISIN
- AU0000442287
- Founded
- 2016
- Listed since
- Sep 20, 2018
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.06T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $650.67B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $377.72B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $365.10B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $300.07B | CHF127.18 | -0.90% |
| AstraZeneca PLCLSE: AZN | $257.89B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $210.23B | Dkr304.95 | -0.93% |
| Pfizer Inc.NYSE: PFE | $161.30B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.